Loading...
•
Dec 31, 2024
SI-BONE Q4 2024 Earnings Report
SI-BONE, Inc. reported record financial results for the fourth quarter of 2024, achieving 26% worldwide revenue growth and positive adjusted EBITDA.
Key Takeaways
SI-BONE, Inc. delivered a strong performance in Q4 2024, with worldwide revenue reaching $49.0 million, a 26% increase year-over-year, and achieving positive adjusted EBITDA of $1.9 million, marking a significant improvement from the previous year.
Worldwide revenue grew by approximately 26% to $49.0 million in Q4 2024.
U.S. revenue increased by approximately 28% to $46.9 million in Q4 2024.
The company achieved positive adjusted EBITDA of $1.9 million in Q4 2024, a 139% improvement.
Net loss improved by 59% to $4.5 million in Q4 2024.
Revenue by Geographic Location
Forward Guidance
SI-BONE expects 2025 worldwide revenue to be in the range of $193.5 million to $195.5 million, implying year-over-year growth of 16% to 17%. The company anticipates gross margin between 77% and 78%, and operating expenses growth of approximately 9% at the mid-point of revenue guidance. Based on these assumptions, SI-BONE expects to deliver positive adjusted EBITDA for the second half and full year 2025.
Positive Outlook
- Anticipated worldwide revenue growth of 16% to 17% for 2025.
- Expected gross margin in the range of 77% to 78% for fiscal year 2025.
- Forecasted positive adjusted EBITDA for the second half and full year 2025.
- Continued expansion of platform adoption.
- Support from reimbursement tailwinds.
Challenges Ahead
- Operating expenses growth expected to be approximately 9% at the mid-point of revenue guidance.
- Potential risks related to the ability to introduce and commercialize new products and indications.
- Potential impact of future economic weakness on patient desire for elective procedures.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...